The Accuracy of Systemic Inflammatory Indices as Preeclampsia Markers:  A Retrospective Study

Harvey Alvin Hartono; Pramudyo Dwiputro

doi:10.24198/obgynia.v9i2.1072

The Accuracy of Systemic Inflammatory Indices as Preeclampsia Markers: A Retrospective Study

Harvey Alvin Hartono, Pramudyo Dwiputro

Abstract

Objective: This study aimed to assess the association between systemic inflammatory indices, including the systemic immune inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), systemic inflammation response index (SIRI), and pan immune inflammation value (PIV), and the development of preeclampsia.
Methods: A retrospective study was performed at a tertiary healthcare facility from January to June 2025. This study employed a cross sectional design involving 100 samples, divided into two groups: the preeclampsia group (n=50) and the control group (n=50). Hematological parameters and inflammatory indices were compared, with a p-value < 0.05 indicating statistical significance.
Results: Normality tests, receiver operating characteristic (ROC) curve analyses, and correlation tests were conducted to evaluate the systemic immune index (SII), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), systemic inflammation response index (SIRI), and pan immune inflammation value (PIV). Both the correlation test and ROC curve analyses showed no significant results for any variable (p > 0.05), with sensitivity and specificity ranging from 50 – 56% and 36 – 62%, respectively.
Conclusion: The preeclampsia group tended to have higher inflammatory parameters, but the differences were not statistically significant. Future research could include additional inflammatory markers, such as CRP and fibrinogen, and consider confounding factors for more accurate results.

Akurasi Indeks Inflamasi Sistemik Sebagai Penanda Preeklamsia: Sebuah Studi Retrospektif

Abstrak
Tujuan: Penelitian ini bertujuan untuk menilai hubungan antara indeks inflamasi sistemik yaitu systemic immune-inflammation index (SII), neutrophil to lymphocyte ratio (NLR), monocyte to lymphocyte ratio (MLR), systemic inflammation response index (SIRI), dan pan immune inflammation value (PIV) dengan kejadian preeklampsia.
Metode: Studi restropektif dilakukan di fasilitas kesehatan tersier periode Januari – Juni 2025. Metode penelitian yang digunakan dalam penelitian ini adalah cross-sectional. Studi ini meliputi 100 sampel, dibagi menjadi 2 kelompok: grup preeklamsia (n=50) dan kontrol (n=50). Parameter hematologi dan indeks inflamasi dibandingkan untuk dianalisis dengan nilai p< 0,05 dianggap signifikan secara statistik.
Hasil: Uji normalitas, receiver operating characteristics (ROC) curve, dan uji korelasi dilakukan untuk menganalisis systemic immune index (SII), neutrophil to lymphocyte ratio (NLR), monocyte to lymphocyte ratio (MLR), systemic inflammation response index (SIRI), dan pan-immune inflammation value (PIV). Hasil uji korelasi dan ROC curve tidak menunjukkan hasil bermakna pada seluruh variabel (p> 0,05) dengan rentang sensitivitas dan spesifisitas masing-masing sebesar 50 – 56% dan 36 – 62%.
Kesimpulan: Kelompok preeklamsia cenderung mempunyai parameter inflamasi lebih tinggi, tetapi tidak berbeda signifikan. Studi berikutnya dapat mengggunakan parameter inflamasi lebih banyak seperti CRP dan fibrinogen, dan menganalisis faktor perancu supaya hasil studi lebih akurat.

Keywords

Hematological parameters; inflammatory index; preeclampsia

Full Text:

PDF

References

Imaralu JO, Walker O, Ani IF, Adediji I, Akadri AA, Adelakun A. Inflammatory Marker Levels in Preeclampsia versus Normal Pregnancies and Prediction of Preeclampsia Occurrence: A Prospective Mixed Methods Study. JCDR. 2023;17(10):21–6. doi: 10.7860/JCDR/2023/64581.18606

Michalczyk M, Celewicz A, Celewicz M, Woźniakowska-Gondek P, Rzepka R. The Role of Inflammation in the Pathogenesis of Preeclampsia. Yi YS, editor. Mediators of Inflammation. 2020 Oct 2;2020:1–9. doi.org/10.1155/2020/3864941

Genc SO, Erdal H. Evaluating Hematological Inflammatory Markers as Predictors of Preeclampsia. Clin Exp Obstet Gynecol. 2024 Jul 19;51(7):163. doi.org/10.31083/j.ceog5107163

Black KD, Horowitz JA. Inflammatory Markers and Preeclampsia: A Systematic Review. Nursing Research. 2018 May;67(3):242–51. doi.org/10.1097/nnr.0000000000000285

Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW, Wallace K, et al. The role of inflammation in the pathology of preeclampsia. Clinical Science. 2016 Mar 1;130(6):409–19. https://doi.org/10.1042/CS20150702

Gao L-N, Yan D, Liu X-H, Chen D, Guo H, Liu J. Association of systemic inflammatory biomarkers (NLR, MLR, PLR, SII, SIRI) with preeclampsia-related kidney injury: a retrospective observational study. J Inflamm Res. 2025;18:12725–12738. doi:10.2147/JIR.S542136

Zhuang Y, Xiao Y, Bai R, Song Y, Lin Z, Yu Y, Chen Q, Wang Z. The association of peripheral blood immunoinflammatory markers with PE and adverse outcomes in preeclampsia: a retrospective study. J Inflamm Res. 2025;18:4359–4366. doi:10.2147/JIR.S504552.

Karagün S, Nessar AZ, Dal Y, Karaca SG, Çevikoğlu Kıllı M, Yıldız H, Coşkun A. Dynamic change of novel systemic inflammation markers in predicting perinatal outcomes after antenatal corticosteroids in preeclampsia. Medicine (United States). 2025;104(50):e46370. doi:10.1097/MD.0000000000046370.

Kwiatek M, Gęca T, Kwaśniewska A. Pro- and Anti-Inflammatory Cytokines in the First Trimester—Comparison of Missed Miscarriage and Normal Pregnancy. IJERPH. 2021 Aug 12;18(16):8538. doi: 10.3390/ijerph18168538

Jarmund AH, Giskeødegård GF, Ryssdal M, Steinkjer B, Stokkeland LMT, Madssen TS, et al. Cytokine Patterns in Maternal Serum From First Trimester to Term and Beyond. Front Immunol. 2021 Oct 14;12:752660. doi.org/10.3389/fimmu.2021.752660

Seyhanli Z, Bayraktar B, Baysoz OB, et al. The role of first trimester serum inflammatory indexes (NLR, PLR, MLR, SII, SIRI, and PIV) and the β-hCG to PAPP-A ratio in predicting preeclampsia. J Reprod Immunol. 2024;162:104190. doi:10.1016/j.jri.2023.104190

Kapci M, Sener K, Cakir A, Altug E, Guven R, Avci A. Prognostic value of systemic immune-inflammation index in the diagnosis of preeclampsia. Heliyon. 2024 Mar;10(6):e28181. doi:10.1016/j.heliyon.2024.e28181

Yücel B, Ustun B. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, red cell distribution width and plateletcrit in preeclampsia. Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health. 2017 Jan;7:29–32. doi:10.1016/j.preghy.2016.12.002

Mensah K, Nkansah C, Appiah SK, Barnie J, Timbilla DT, Daud S, et al. Predictive Values of NLR, PLR and MPV for Pre-Eclampsia in Pregnancy: A Retrospective Cross Sectional Study in a Teaching Hospital, Ghana. IJR2H. 2022;5(2):264–73.

Çintesun E, Çintesun FNI, Ezveci H, Akyürek F, Çelik Ç. Systemic inflammatory response markers in preeclampsia. https://doi.org/10.4103/JLP.JLP_144_17

J Lab Physicians. 2018 Jul;10(03):316–9. doi:10.4103/JLP.JLP_144_17

Mannaerts D, Heyvaert S, De Cordt C, Macken C, Loos C, Jacquemyn Y. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia? The Journal of Maternal-Fetal & Neonatal Medicine. 2019 May 3;32(9):1412–9. doi:10.1080/14767058.2017.1410701

Tokgöz Çakır B, Aktemur G, Karabay G, Şeyhanlı Z, Çetin S, Filiz AA, et al. Evaluation of Platelet Indices and Inflammation Markers in Preeclampsia. JCM. 2025 Feb 20;14(5):1406. doi:10.3390/jcm14051406

Jancsura MK, Schmella MJ, Helsabeck N, Gillespie SL, Roberts JM, Conley YP, et al. Inflammatory markers are elevated in early pregnancy, but not late pregnancy, in women with overweight and obesity that later develop preeclampsia. American J Rep Immunol. 2023 Sep;90(3):e13763. doi:10.1111/aji.13763

Bränn E, Edvinsson Å, Rostedt Punga A, Sundström-Poromaa I, Skalkidou A. Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum. Sci Rep. 2019 Feb 12;9(1):1863. doi.org/10.1038/s41598-018-38304-w

Sahin R, Inceoglu C and Tahiroglu V. The value of first trimester inflammatory indices in predicting the development of preeclampsia in the third trimester. Turkey: Department of Obstetrics and Gynecology, Sirnak State Hospital. (2025) 25:713. https://doi.org/10.1186/s12884-025-07836-1

Maziashvili G, Juliana K, Siva Subramania Pillai K, et al. The use of systemic inflammatory markers from routine blood tests in predicting preeclampsia and the impact of age on marker levels. Cureus. 2023;15(3):e35836. doi:10.7759/cureus.35836

Özkan S, Dereli ML, Firatligil FB, Kurt D, Kurt A, Sucu ST, Sucu S, Celen S, Engin-Ustun Y. Role of systemic immune-inflammation index, systemic inflammation response index, and pan-immune inflammation value in the prediction of preeclampsia: a retrospective cohort study. Am J Reprod Immunol. 2024;92(6):e70029. doi:10.1111/aji.70029

Karabay G, Bayraktar B, Seyhanli Z, Cakir BT, Aktemur G, Sucu ST, et al. Predictive value of inflammatory markers (NLR, PLR, MLR, SII, SIRI, PIV, IG, and MII) for latency period in Preterm premature rupture of membranes (PPROM) pregnancies. BMC Pregnancy Childbirth. 2024 Aug 30;24(1):564. doi:10.1186/s12884-024-06756-w

DOI: http://dx.doi.org/10.24198/obgynia.v9i2.1072